SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastems VS-7375 clinical update is the main focus, with the company reporting encouraging KRAS G12D activity, including a 50% confirmed response rate in second-line pancreatic cancer, alongside favorable tolerability. Traders are weighing the results potential against the stocks decline and a newly priced share offering; some view the offering price as investor confidence, while others are concerned about dilution.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is under pressure amid a broader AI-infrastructure selloff, as OpenAI revenue disclosures renewed doubts about whether AI demand can support the sectors heavy buildout. Bears are also focused on CoreWeaves debt, capital spending and financing costs, while bulls call the demand concerns overblown and point to its backlog and capacity expansion.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Skydance Corp. - Ordinary Shares - Class B

Skydances distribution of long-dated warrants and the shift to ex-warrant trading dominate discussion, with traders debating whether the share-price adjustment reflects the warrants separated value or additional selling pressure. Concerns about potential dilution and the debt burden from the Warner Bros. Discovery deal add to the bearish reaction, while some holders argue the warrants offset the stocks decline.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Discussion centers on new immune-biomarker findings for Candels CAN-2409 prostate cancer program and the planned BLA submission, with bullish traders viewing the data as support for the treatments potential and regulatory case. Others remain concerned about the stocks decline despite positive updates, BLA timing, and possible dilution, with some also criticizing the CEOs share sale.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidias settlement with United Therapeutics resolves their litigation and keeps YUTREPIA available for PAH, while the PH-ILD indication is being removed. Traders see relief from the risk of losing access to the market, but debate whether the costly settlement and lost indication outweigh that benefit.

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

United Therapeutics Corp

United Therapeutics global settlement with Liquidia resolves six lawsuits and keeps YUTREPIA available for PAH while removing its PH-ILD indication, a development traders view as protecting UTHRs Tyvaso franchise. Some posts note that Liquidias continued PAH sales limit the competitive impact, while others question why UTHR shares have reacted modestly to the deal.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

CEO Ryan Cohens latest large open-market share purchase, continuing a run of insider buying, is driving attention. Many traders view it as a bullish signal and link it to warrant-related or short-squeeze speculation, while others argue insider purchases alone are not a substitute for meaningful company news.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASMLs quarterly results and raised full-year sales outlook are driving discussion, with management citing strong AI-related equipment demand that may outstrip planned supply in coming years. Traders are divided over the share-price decline: bulls call it a sell-the-news reaction to solid results and demand, while skeptics point to a slight sales miss and the lack of a 2027 outlook.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

FDA review details highlighting a lower response rate for Revolution Medicines daraxonrasib in the KRAS G12D subgroup have fueled scrutiny of the drugs efficacy and contributed to discussion of RVMDs pullback. Traders disagree on how much the subgroup result matters, weighing response rates against survival data and comparing the drug with Verastems competing KRAS G12D program.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention ahead of the final analysis of its Phase 3 REGAL trial in AML, with traders focused on the pending 80th-death milestone and eventual GPS results. Trading and options activity has fueled unconfirmed speculation about a data leak, short covering, or a buyout, while others stress that no trial outcome or deal has been confirmed.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Versigent Announces Third Quarter 2026 Earnings Call Details

Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low- and high-voltage electrical architectures, today announced it will release its third quarter 2026 financial results before the market opens on the New York Stock Exchange on Wednesday, November 4, 2026. At 8 a.m. ET...

Versigent Q2 2026 Earnings Call Transcript

Versigent (NYSE:VGNT) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below.
Benzinga APIs provide real-time access to earnings call transcripts andread more...

Versigent Q2 Earnings Call Highlights

Versigent Reports Second Quarter 2026 Results

Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low and highvoltage electrical architectures, today reported results for its second quarter ended June 30, 2026. Highlights Second Quarter 2026 Net sales of $2,444 million, up 10.8% year-over-year Adjusted Net Sales...

Evergy Set to Report Q2 Earnings: Here's What You Need to Know

EVRG heads into Q2 earnings with demand growth, data center activity and infrastructure investments poised to support results, while higher costs may have weighed.

NRG Energy Gears Up to Report Q2 Earnings: Here's What to Expect

NRG heads into Q2 earnings with expectations under pressure, while new generation capacity, data center demand and share repurchases may support its quarterly results.

NiSource to Release Q2 Earnings: Here's What You Need to Know

NI heads into Q2 earnings with load growth, data center demand, infrastructure spending and cost discipline poised to support results despite lower earnings expectations.

Versigent Announces Second Quarter 2026 Earnings Call

Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low and highvoltage electrical architectures, today announced that it will release its second quarter 2026 financial results before the market opens on the New York Stock Exchange on Tuesday, August 4, 2026. Versigent will...

Versigent Announces Participation in June Investor Conferences

Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low and highvoltage electrical architectures, today announced that management will participate in the following investor...

Aptiv Q1 Earnings Call Highlights

Aptiv (NYSE:APTV) reported first-quarter 2026 results alongside the completion of a major portfolio shift, after the company separated its Electrical Distribution Systems (EDS) business into a newly independent public company, Versigent. Executives said the move sharpens Aptiv's focus on advanced so...

Versigent Plc engages in the design, manufacturing, supplies low voltage and high voltage electrical architectures for automotive and commercial vehicle markets. It offers versatile, intelligent solutions to automotive, commercial vehicles, agriculture and energy storages. The firm focuses on signal, power and data distribution which supports increased vehicle content, electrification, enables increased safety, reduced emissions and enhanced vehicle connectivity. The company is headquartered in Schaffhausen, Switzerland.

Versigent PLC.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$43.65
Prev Close	$43.44
Open	$43.40
Dividend Yield	N/A
50-Day Moving Average	$46.24
Beta	-0.28
Avg. Volume	765,132.46
PE Ratio	N/A

52-Week High	$50.89
52-Week Low	$26.34
Market Capitalization	$3.08B
EPS (Annual)	$7.43
Price to Book	36.37
Revenue Per Employee	$63,898.55

Feed

News

Sentiment

Fundamentals

Info

VGNT Fundamentals